Literature DB >> 23359103

Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease.

Kazuomi Mizuuchi1, Nobuyoshi Kitaichi, Kenichi Namba, Yukihiro Horie, Susumu Ishida, Shigeaki Ohno.   

Abstract

PURPOSE: Since some patients develop depigmentation of the trabecular meshwork in the course of Vogt-Koyanagi-Harada (VKH) disease, we examined the incidence of trabecular depigmentation and its correlation with other ocular findings and systemic symptoms.
METHODS: We retrospectively reviewed the clinical charts of 53 Japanese patients diagnosed with VKH disease. The scores of trabecular and limbal pigmentation of all patients were recorded. We then examined the correlation between trabecular pigmentation and the presence of sunset glow fundus or skin lesions.
RESULTS: Trabecular pigmentation was significantly lower in the patients with sunset glow fundus than in those without it (P = 0.022), whereas limbal pigmentation showed no significance. However, there were no significant differences in trabecular and limbal pigmentation between the patients with and those without skin lesions. Furthermore, there was no correlation between trabecular and limbal pigmentation.
CONCLUSIONS: Depigmentation of the trabecular meshwork develops in some patients in the course of VKH disease. This depigmentation is significantly correlated with sunset glow fundus, but not with limbal depigmentation or skin lesions.

Entities:  

Mesh:

Year:  2013        PMID: 23359103     DOI: 10.1007/s10384-012-0229-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Symmetric peripheral iris depigmentation in vogt-koyanagi-harada syndrome.

Authors:  Eric B Suhler; Ronald R Buggage; Robert B Nussenblatt; Ron Neumann
Journal:  Arch Ophthalmol       Date:  2002-08

2.  Width and pigmentation of the angle of the anterior chamber; a system of grading by gonioscopy.

Authors:  H G SCHEIE
Journal:  AMA Arch Ophthalmol       Date:  1957-10

Review 3.  Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome.

Authors:  H Goto; N A Rao
Journal:  Int Ophthalmol Clin       Date:  1990

Review 4.  Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome.

Authors:  N A Rao
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  Iris atrophy, serous detachment of the ciliary body, and ocular hypotony in chronic phase of Vogt-Koyanagi-Harada disease.

Authors:  J M Saari; K Nummelin
Journal:  Eur J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.597

6.  Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.

Authors:  S Sugita; K Sagawa; M Mochizuki; S Shichijo; K Itoh
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

7.  Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Authors:  K Norose; A Yano
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

8.  Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.

Authors:  K Yamaki; K Gocho; K Hayakawa; I Kondo; S Sakuragi
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

Review 10.  Vogt-Koyanagi-Harada syndrome.

Authors:  R S Moorthy; H Inomata; N A Rao
Journal:  Surv Ophthalmol       Date:  1995 Jan-Feb       Impact factor: 6.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.